Marypaul EMSL

The DAK Group Announces Sale of Marypaul Laboratories, Inc. to EMSL Analytical, Inc

The DAK Group, the leading investment bank specializing in middle- market mergers and acquisitions worldwide, announces the sale of its client Marypaul Laboratories, Inc. of Sparta, NJ to EMSL Analytical, Inc. with corporate headquarters in Cinnaminson, NJ. The DAK Group served as the exclusive investment banker and financial advisor to Marypaul, initiating the transaction and managing the divestiture process. The transaction capitalizes on Marypaul’s outstanding reputation in the industry as a high-quality service provider, as well as its deep relationships with clients in the pharmaceutical, cosmetic, personal care, food ingredients and water industries — some spanning 20-30 years.

The acquisition marks the expansion strategy for EMSL Analytical, Inc., who plan to offer Marypaul’s services to its current customers, served in 40 locations throughout the US and Canada. In addition, Marypaul’s clients will now have access to EMSL’s vast array of services. EMSL will maintain the Marypaul staff and facility in Sparta, NJ and plans on a seamless transition.

“We have built a niche business in microbiology testing focused on providing high-quality service and instilling confidence in our customers who entrust us with their critical products,” said Marypaul President, Dr. Paul La Rocca. “This transaction will provide the capital and resources to offer our customers a full range of comprehensive analytical testing services to augment and compliment the core competency of MPL.”

“We are pleased to have delivered significant value to Marypaul’s ownership using our unique worldwide, proprietary process to identify the right buyer,” said Michael Richmond, the Managing Director who led the DAK transaction team. “This acquisition is a tremendous opportunity for a deeper penetration of Marypaul’s services into the marketplace and the ideal fit to serve as part of EMSL’s growth strategy.”

The successful sale of Marypaul Laboratories, Inc. was a result of a highly competitive process initiated by The DAK Group, who identified the strategic fit between these two companies.

About Marypaul Laboratories, Inc.
Marypaul Laboratories, Inc. ( is a leading, full-service microbiology contract testing laboratory serving a variety of industries including: pharmaceutical, cosmetic and personal care, food ingredients, and water.

The company has long-term relationships with many of the top-ranked manufacturers in these industries and is well-known for its passion for excellence in the services it provides to its loyal customers.

About EMSL Analytical, Inc.
EMSL Analytical, Inc. ( is the nation’s leading environmental testing firm and has been providing quality analytical services since 1981. They offer a wide array of analytical testing services to support environmental investigations focused on asbestos, microbiology, environmental chemistry, indoor air quality, industrial hygiene, radiochemistry, and food testing. Additionally, they provide materials testing, characterization, and forensic laboratory services for a wide range of commercial, industrial, regulatory, and law enforcement clients.

Share the Post:

Current Posts

Scroll to Top

VCI – Emergency Vehicle Specialists recapitalized by Tightrope Capital & NewSpring Capital

VCI is the preeminent full lifecycle sales and service provider of emergency ambulance solutions to first aid squads, EMS organizations, fire departments, hospital organizations, municipalities, and private medical transport companies in the Mid-Atlantic Region. VCI was recapitalized by private equity firms Tightrope Capital Partners and NewSpring Capital.

DAK led a competitive, sell-side process for VCI, generating multiple offers from a wide range of strategic buyers and financial sponsors. By positioning the combination of VCI’s market leadership position, comprehensive services offering, strong manufacturer relationships, and robust backlog, DAK achieved an outstanding outcome for the company’s shareholders.

The acquisition provides the shareholders of VCI an opportunity to accelerate its growth strategy by expanding its core ambulance business, building out the value-added segments of conversions and remounts, implementing operational improvements, and pursuing acquisitions with the help of its new partners. Tightrope and NewSpring have an opportunity to leverage VCI’s strong management team and operating platform to build a multi-regional player in emergency ambulance solutions.

Skip to content